VHCP Management III, LLC
CIK 1738053 · last filed 2024-02-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.78M
Companies
5
Total Filings
14
Lifetime Open-Market Net
$345.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | 10%+ Owner | 4,738,683 | $27.00 | $127.94M | $11.26M | 2 | 2024-02-01 |
| Tricida, Inc. (TCDA) Delisted | 10%+ Owner | 8,088,998 | $0.11 | $873.6K | $43.29M | 6 | 2022-10-26 |
| ALT | 10%+ Owner | 4,500,000 | $2.84 | $12.78M | $181.64M | 2 | 2020-06-15 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | 10%+ Owner | 4,016,873 | $33.99 | $136.53M | $110.40M | 1 | 2019-12-16 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | 10%+ Owner | 429,012 | $0.01 | $5.1K | -$1.43M | 3 | 2019-10-28 |
Recent Filings · Page 2 of 2
14 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-16 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Buy (P) | +3,200,000 | $110.40M | EDGAR |
| 2019-10-28 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Sell (S) | −5,469,235 | -$2.62M | EDGAR |
| 2019-03-14 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +714,285 | $500.0K | EDGAR |
| 2018-09-07 | Bellerophon Therapeutics, Inc. (BLPH) Delisted | Buy (P) | +800,000 | $690.8K | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.